Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05252832 · ClinicalTrials.gov registry record · NA
Superficial Cervical Plexus Block for IJCL Pain Management
A NA study, sponsored by Cleveland Clinic Akron General.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT05252832: Completed NA study, sponsored by Cleveland Clinic Akron General.
NCT05252832 is a NA study that has completed, run by Cleveland Clinic Akron General. The registered enrollment target is 14 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05252832, a NA study, has completed, sponsored by Cleveland Clinic Akron General.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
This is a prospective randomized trial evaluating the effect of SCPB on reported patient pain following IJCL placement as compared to local infiltrate.
Primary Outcome
The average Visual Analog Scale (VAS) rating in patients who receive the SCPB during internal jugular venous cannulation versus the average VAS in patients receiving local infiltration. The scale is from 0-10, with 0 meaning no pain and 10 meaning the most pain I have ever experienced.
Interventions
- PROCEDURE Superficial Cervical Plexus Block
- PROCEDURE Local Infiltrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-01-15 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT05252832 record still lists
NCT05252832 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Superficial Cervical Plexus Block is the first listed.
NCT05252832 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05252832 about?
NCT05252832 is a clinical study titled "Superficial Cervical Plexus Block for IJCL Pain Management". This is a prospective randomized trial evaluating the effect of SCPB on reported patient pain following IJCL placement as compared to local infiltrate.
What is the current status of trial NCT05252832?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-01-15. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05252832?
The interventions under investigation include: Superficial Cervical Plexus Block (PROCEDURE), Local Infiltrate (PROCEDURE).
Who is sponsoring clinical trial NCT05252832?
This trial is sponsored by Cleveland Clinic Akron General, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05252832's enrollment target sits among peer trials
14 1909th of 2000 higher than 90 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT06358040 · started 2026-10 · NA
Opioid Dispenser for Microdiscectomy/Laminectomy